Dr. Reddy's launches Toripalimab in India, the first and only immunooncology drug approved for the treatment of nasopharyngeal carcinoma Read more about Dr. Reddy's launches Toripalimab in India, the first and only immunooncology drug approved for the treatment of nasopharyngeal carcinoma
We have Voluntary Licence from Gilead to make the latest generation HIV drug lenacapavir accessible to patients in 120 countries! Read more about We have Voluntary Licence from Gilead to make the latest generation HIV drug lenacapavir accessible to patients in 120 countries!
A big step towards building our consumer healthcare business globally Read more about A big step towards building our consumer healthcare business globally
Our whitepaper on the topic 'Emerging Frameworks in Innovation' Read more about Our whitepaper on the topic 'Emerging Frameworks in Innovation'